(8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol(CAS: 53910-25-1)

(8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol is a crystalline compound with a molecular weight of approximately 289.30 g/mol. It has a solubility of about 0.1 mg/mL in water. The compound is known for its low reactivity under normal conditions but can be unstable in strong acids and bases. It is also sensitive to light and air exposure.

(8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol is typically synthesized through a multi-step process involving the condensation of 2-deoxy-D-erythro-pentofuranosyl bromide with 3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol. The synthesis involves the use of anhydrous conditions and is carried out in the presence of a suitable catalyst to ensure high selectivity and yield.

(8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol is primarily used in the pharmaceutical industry for the development of novel drugs. It is also of interest in the research of biologically active compounds and has potential applications in the production of sensors and semiconductors due to its unique structural properties.

When handling (8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, it is essential to wear proper personal protective equipment (PPE) including gloves, goggles, and a lab coat. The compound should be handled in a well-ventilated area or a fume hood. Spills should be cleaned up immediately using appropriate absorbent materials and the area should be flushed with water. Always refer to the Safety Data Sheet (SDS) for detailed handling and emergency procedures.